ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

Diisopropylethylamine → (2S,4R)-methyl 4-(6-amino-5-(4-(((S)-1-(3-chlorophenyl)-2-hydroxyethyl)carbamoyl)-3-fluorophenyl)pyridin-3-yl)pyrrolidine-2-carboxylate

HRID 596108
ノート
印刷プレビュー

反応式

HRID 596108 の反応式
[OH:1][C:2]([C:4](F)(F)F)=[O:3].O[C:9](C(F)(F)F)=O.[NH2:15][C:16]1[C:21]([C:22]2[CH:30]=[CH:29][C:25]([C:26](O)=[O:27])=[C:24]([F:31])[CH:23]=2)=[CH:20][C:19]([C@H:32]2[CH2:36][C@@H](C(OC)=O)[NH:34][CH2:33]2)=[CH:18][N:17]=1.CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.CCN(C(C)C)C(C)C.[NH2:74][C@@H:75]([C:78]1[CH:83]=[CH:82][CH:81]=[C:80]([Cl:84])[CH:79]=1)[CH2:76][OH:77]>CN(C=O)C>[NH2:15][C:16]1[N:17]=[CH:18][C:19]([C@@H:32]2[CH2:33][NH:34][C@H:4]([C:2]([O:1][CH3:9])=[O:3])[CH2:36]2)=[CH:20][C:21]=1[C:22]1[CH:30]=[CH:29][C:25]([C:26](=[O:27])[NH:74][C@@H:75]([C:78]2[CH:83]=[CH:82][CH:81]=[C:80]([Cl:84])[CH:79]=2)[CH2:76][OH:77])=[C:24]([F:31])[CH:23]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

6

反応物 4

HCID 81531DiisopropylethylamineHCID 9886157Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 59694427(S)-2-amino-2-(3-chlorophenyl)ethanolHCID 1317346254-(2-amino-5-((3R,5S)-5-(methoxycarbonyl)pyrrolidin-3-yl)pyridin-3-yl)-2-fluorobenzoic acid-2TFA

生成物 1

HCID 118045925
(2S,4R)-methyl 4-(6-amino-5-(4-(((S)-1-(3-chlorophenyl)-2-hydroxyethyl)carbamoyl)-3-fluorophenyl)pyridin-3-yl)pyrrolidine-2-carboxylate
収率 13.6%

試薬・触媒・溶媒 1

HCID 6228Dimethylformamide溶媒

実験手順

A mixture of 4-(2-amino-5-((3R,5S)-5-(methoxycarbonyl)pyrrolidin-3-yl)pyridin-3-yl)-2-fluorobenzoic acid-2TFA (35 mg, 0.060 mmol), HATU (34 mg, 0.089 mmol), and DIEA (0.104 mL, 0.596 mmol) in DMF (2 mL) was treated with (S)-2-amino-2-(3-chlorophenyl)ethanol (51 mg, 0.348 mmol). At completion, the reaction was washed with water and brine, then dried over MgSO4 and concentrated. The crude material was purified by reverse phase prep HPLC to provide (2S,4R)-methyl 4-(6-amino-5-(4-(((S)-1-(3-chlorophenyl)-2-hydroxyethyl)carbamoyl)-3-fluorophenyl)pyridin-3-yl)pyrrolidine-2-carboxylate (4.2 mg, 9%). LCMS (m/z): 513.2, 515.2 (MH+), 0.58 min; 1H NMR (400 MHz, CD3OD) δ ppm 7.97-7.86 (m, 3H), 7.49-7.40 (m, 3H), 7.39-7.34 (m, 2H), 7.33-7.26 (m, 1H), 5.19 (t, J=5.87 Hz, 1H), 4.62 (dd, J=7.63, 10.76 Hz, 1H), 3.93-3.77 (m, 6H), 3.74-3.61 (m, 1H), 2.87 (td, J=6.90, 13.21 Hz, 1H), 2.33-2.21 (m, 1H).

後処理

  1. washAt completion, the reaction was washed with water and brine
  2. dry with materialdried over MgSO4
  3. concentrationconcentrated
  4. customThe crude material was purified by reverse phase prep HPLC

出典と根拠

ORDレコード
ord-f7024074b5e6447bb5d733f6751b308e
出典データセット
uspto-grants-2016_01
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US09242996B2

反応ノート

読み込み中…

このページの内容参加物実験手順後処理出典と根拠反応ノート